Literature DB >> 18375525

Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.

G Jaeger, F Bauer, R Brezinschek, C Beham-Schmid, C Mannhalter, P Neumeister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375525     DOI: 10.1093/annonc/mdn119

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.

Authors:  Murat Albayrak; Ozlem Sahin Balcik; Saadet Alan; Suleyman Lütfü Dıncer; Meltem Kurt Yüksel; Aynur Albayrak
Journal:  Pathol Oncol Res       Date:  2011-01-01       Impact factor: 3.201

2.  Aggressive Lymphomas Diagnosed in the Bone Marrow: Two Illustrative Cases.

Authors:  Rekha Bhat; Swati Pai; Kunal Das; Ashish Dixit
Journal:  Indian J Hematol Blood Transfus       Date:  2015-02-26       Impact factor: 0.900

Review 3.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

Review 4.  Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Authors:  Barbara Pro; Pamela Allen; Amir Behdad
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

5.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

6.  Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.

Authors:  Eric Schafer; Allen Chen; Robert J Arceci
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

7.  Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis.

Authors:  Jonah Cohen; Eduardo Hariton; Darshan Kothari; German A Pihan; Simon C Robson
Journal:  J Gastrointest Oncol       Date:  2013-06

8.  The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms.

Authors:  Jew Win Kuan; Kian Meng Chang; Ngee Siang Lau; Purushothaman Visalachy; Sen Mui Tan; Tee Chuan Ong; Anselm Ting Su
Journal:  Indian J Hematol Blood Transfus       Date:  2011-06-05       Impact factor: 0.900

9.  An Unusual Case of Hepatosplenic αβ T-Cell Lymphoma Presenting with Coombs'-Negative Hemolytic Anemia.

Authors:  Feryal A Ibrahim; Vignesh Shanmugam; Aliaa Amer; Halima El-Omri; Ahmad Al-Sabbagh; Ruba Y Taha; Dina S Soliman
Journal:  Clin Med Insights Oncol       Date:  2015-12-02

10.  Hepatosplenic gamma-delta T-cell lymphoma in a female patient after delivery.

Authors:  Marjana Glaser; Aleš Goropevšek; Rajko Kavalar; Andrej Glaser
Journal:  Hematol Rep       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.